Vor Biopharma
VOR
VOR
48 hedge funds and large institutions have $125M invested in Vor Biopharma in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
2% less funds holding
Funds holding: 49 → 48 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
17% less capital invested
Capital invested by funds: $151M → $125M (-$25.6M)
Holders
48
Holding in Top 10
3
Calls
$31K
Puts
$20K
Top Buyers
| 1 | +$1.59M | |
| 2 | +$1.3M | |
| 3 | +$1.02M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$834K |
| 5 |
Millennium Management
New York
|
+$199K |
Top Sellers
| 1 | -$264K | |
| 2 | -$226K | |
| 3 | -$168K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$124K |
| 5 |
Morgan Stanley
New York
|
-$88.4K |